These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34609400)
1. Cytotoxicity evaluation and DNA interaction of Ru de Almeida PSVB; de Arruda HJ; Sousa GLS; Ribeiro FV; de Azevedo-França JA; Ferreira LA; Guedes GP; Silva H; Kummerle AE; Neves AP Dalton Trans; 2021 Oct; 50(41):14908-14919. PubMed ID: 34609400 [TBL] [Abstract][Full Text] [Related]
2. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents. Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686 [TBL] [Abstract][Full Text] [Related]
3. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7). Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726 [TBL] [Abstract][Full Text] [Related]
4. Coumarin-modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells. Jakopec S; Hamzic LF; Bočkor L; Car I; Perić B; Kirin SI; Sedić M; Raić-Malić S Arch Pharm (Weinheim); 2024 Sep; 357(9):e2400271. PubMed ID: 38864840 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding. Sangeetha S; Murali M Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation. Chakraborty A; Roy S; Chakraborty MP; Roy SS; Purkait K; Koley TS; Das R; Acharya M; Mukherjee A Inorg Chem; 2021 Dec; 60(23):18379-18394. PubMed ID: 34780170 [TBL] [Abstract][Full Text] [Related]
7. Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos. Lenis-Rojas OA; Fernandes AR; Roma-Rodrigues C; Baptista PV; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; Torres ML; Fernández A; Fernández JJ Dalton Trans; 2016 Dec; 45(47):19127-19140. PubMed ID: 27868117 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA. Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415 [TBL] [Abstract][Full Text] [Related]
10. Insights into the antineoplastic activity and mechanisms of action of coumarin-coordinated 8-hydroxyquinoline ruthenium(II/III) compounds. Du LQ; Yang Y; Ruan L; Sun S; Mo DY; Cai JY; Liang H; Shu S; Qin QP J Inorg Biochem; 2024 Oct; 259():112659. PubMed ID: 38976937 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological properties of tetranuclear ruthenium complexes containing the bis[4(4'-methyl-2,2'-bipyridyl)]-1,7-heptane ligand. Sun B; Sundaraneedi MK; Southam HM; Poole RK; Musgrave IF; Keene FR; Collins JG Dalton Trans; 2019 Oct; 48(38):14505-14515. PubMed ID: 31531475 [TBL] [Abstract][Full Text] [Related]
12. Pyrazolone incorporating bipyridyl metallointercalators as effective DNA, protein and lung cancer targets: Synthesis, characterization and in vitro biocidal evaluation. Vyas KM; Devkar RV; Prajapati A; Jadeja RN Chem Biol Interact; 2015 Oct; 240():250-66. PubMed ID: 26341650 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A. Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006 [TBL] [Abstract][Full Text] [Related]
15. Mixed ligand ruthenium(II) complexes of bis(pyrid-2-yl)-/bis(benzimidazol-2-yl)-dithioether and diimines: study of non-covalent DNA binding and cytotoxicity. Rajendiran V; Murali M; Suresh E; Sinha S; Somasundaram K; Palaniandavar M Dalton Trans; 2008 Jan; (1):148-63. PubMed ID: 18399241 [TBL] [Abstract][Full Text] [Related]
16. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes. Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, cellular uptake, apopotosis, cytotoxicity, cell cycle arrest, interaction with DNA and antioxidant activity of ruthenium(II) complexes. Huang HL; Li ZZ; Liang ZH; Yao JH; Liu YJ Eur J Med Chem; 2011 Aug; 46(8):3282-90. PubMed ID: 21570748 [TBL] [Abstract][Full Text] [Related]
18. Spectral characteristics, DNA-binding and cytotoxicity of two functional Ru(II) mixed-ligand complexes. Tan L; Shen J; Liu J; Zeng L; Jin L; Weng C Dalton Trans; 2012 Apr; 41(15):4575-87. PubMed ID: 22358386 [TBL] [Abstract][Full Text] [Related]